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Abstract
Background—While several MRI parameters are used to assess tissue perfusion during
hyperacute stroke, it is unclear which is optimal for measuring clinically-relevant reperfusion. We
directly compared MTT prolongation (MTTp), TTP, and time-to-maximum (Tmax) to determine
which best predicted neurological improvement and tissue salvage following early reperfusion.
Methods—Acute ischemic stroke patients underwent three MRI's: <4.5hr (tp1), at 6hr (tp2), and
at 1 month after onset. Perfusion deficits at tp1 and tp2 were defined by MTTp, TTP, or Tmax
beyond four commonly-used thresholds. Percent reperfusion (%Reperf) was calculated for each
parameter and threshold. Regression analysis was used to fit %Reperf for each parameter and
threshold as a predictor of neurological improvement [defined as admission National Institutes of
Health Stroke Scale (NIHSS) – 1 month NIHSS (ΔNIHSS)] after adjusting for baseline clinical
variables. Volume of reperfusion, for each parameter and threshold, was correlated with tissue
salvage, defined as tp1 perfusion deficit volume – final infarct volume.
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Results—50 patients were scanned at 2.7 hours and 6.2 hours after stroke onset. %Reperf
predicted ΔNIHSS for all MTTp thresholds, for Tmax > 6s and > 8s, but for no TTP thresholds.
Tissue salvage significantly correlated with reperfusion for all MTTp thresholds and with Tmax >
6s, while there was no correlation with any TTP threshold. Among all parameters, reperfusion
defined by MTTp was most strongly associated with ΔNIHSS (MTTp>3s, p=0.0002) and tissue
salvage (MTTp> 3s and 4s, P<0.0001).
Conclusion—MTT-defined reperfusion was the best predictor of neurological improvement and
tissue salvage in hyperacute ischemic stroke.
Introduction
MRI and CT have been extensively studied in acute ischemic stroke to identify early
signatures which can delineate the ischemic penumbra--non-functioning, but viable tissue
which can be salvaged with reperfusion.[1] Because of the reperfusion-dependence of tissue
outcome in the ischemic penumbra, finding the ideal measure for perfusion and reperfusion
is essential towards the goal of developing “penumbral imaging.” Calculating absolute CBF
and CBV using bolus-tracking methods requires several assumptions which are prone to
error when applied clinically.[2] Moreover, CBF and CBV values vary two to three fold
between gray and white matter.[3] These limitations have led to the development of
perfusion parameters based on the temporal characteristics of the intravascular contrast
signal after intravenous injection. These “time-based” perfusion parameters have the
advantage over CBF and CBV maps of being uniform across gray and white matter,
allowing for easier visual detection of perfusion lesions and obviating the need for gray-
white segmentation. While several parameters have been studied, the three most commonly
used in stroke trials[4-6] are: (1) MTT defined as CBV/CBF, (2) TTP defined as the time
from contrast arrival (of the arterial input function) to the time of maximal tissue
concentration, and (3) time-to-maximum (Tmax), defined as time at which the maximum
value of the residue function occurs after deconvolution.[2]
Effective tissue reperfusion (perfusion restoration sufficient to meet metabolic demand) is a
critical determinant for salvage of the ischemic penumbra and subsequent clinical
improvement when accomplished early after arterial occlusion.[1] With the advent of non-
invasive, rapid methods to measure local perfusion using MR and CT, reperfusion has
served as an imaging endpoint in recent stroke trials evaluating the efficacy of acute
reperfusion therapies in patients with diffusion- or CT-perfusion mismatch.[4-6] While
reperfusion, measured in a variety of ways, is associated with less infarct growth [7, 8] and
improved clinical outcome after stroke,[8-10] it is not clear which perfusion parameter is
optimal for detecting clinically-effective reperfusion as they have not been directly
compared for prediction of neurological improvement and tissue salvage within a single
study. Therefore, we investigated MTT, TTP, and Tmax to determine which reperfusion
measurement was most strongly associated with neurological improvement (“clinically-
relevant” reperfusion) and tissue salvage during acute ischemic stroke.
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Patients and Inclusion Criteria
This study utilized data collected from a prospective observational MRI study in acute
ischemic stroke patients at a large, urban, tertiary care referral center. After approval from
the institutional review board, consecutive patients were enrolled within 4.5 hours of stroke
onset based on the following pre-specified inclusion criteria: clinically-suspected acute
cortical ischemic stroke; age ≥ 18 years; NIHSS ≥ 5; and patient or patient's next of kin
capable of providing written informed consent. Exclusion criteria included bilateral strokes,
infratentorial stroke, contraindication to MRI or MRI contrast, pregnancy, or any acute
endovascular intervention. Both IV tPA-treated and untreated patients were included. The
study imposed no delay in time-to-tPA treatment and no deviation from standard monitoring
practices or standard inclusion/exclusion criteria for IV tPA administration. The NIHSS was
collected prospectively by a stroke neurologist or research coordinator on admission, at all
imaging time-points, and at one month follow-up. Clinical data including demographic data
and past medical history were obtained by the coordinator prospectively at the time of
patient enrollment.
Magnetic Resonance Imaging Protocol
Patients underwent serial MRI scans within 4.5 hours (tp1), at 6 hours (tp2), and at 1 month
after stroke onset, on a 3T Siemens whole body Trio scanner with a 12-channel head coil.
For tPA-treated patients, tp1 was performed as soon as possible after IV tPA bolus (during
tPA infusion). Because tissue fate depends on the history of perfusion change during the
hyperacute phase of ischemia (while tissue may still be reversibly injured), we measured
tissue reperfusion within the first six hours of onset to examine the correlation between
reperfusion and clinical improvement. Six hours was chosen because reperfusion-based
therapies administered within, but not beyond, this time-frame have demonstrated clinical
efficacy.[11, 12]
The protocol included diffusion-weighted, FLAIR [TR/TE=10000/115ms; inversion time =
2500ms; matrix=512×416; 20 slices, slice thickness (TH)=5mm], and dynamic susceptibility
contrast perfusion images with 0.2ml/kg gadolinium injected at 5ml/sec (T2*-weighted
gradient echo EPI sequence; TR/TE=1500/43ms; 14 slices, TH=5mm, zero interslice gap;
matrix=128×128).
Image Post-Processing and Data Analysis
MTT, TTP, and Tmax maps were calculated for each patient at tp1 and tp2. Voxels within
the middle cerebral artery (MCA) of the contralateral hemisphere were manually chosen and
the mean concentration curve of these voxels was used as the arterial input function (AIF).
Perfusion parameters were calculated according to the following equation:
(1)
where Ct(t)=relative contrast agent concentration in the tissue at time t, derived from the
T2* relaxation rate change under the assumption of linearity; Ca(t)=the AIF; and R(t)=the
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unit impulse response of the residue function, a measure of the amount of tracer in the voxel
at time t.[2] Convolution (represented by ⊗) is necessary to calculate the tissue
concentration curve as the true AIF is temporally distributed, made up of multiple short
impulses over time, rather than a single unit impulse function. TTP was calculated as the
time from AIF contrast bolus arrival to the time of maximal Ct(t). Relative CBV was
computed as the ratio of [the integral of tissue concentration curve, Ct(t)] / [the integral of
the AIF curve, Ca(t)]. To minimize time lag effects of the AIF on perfusion measurements, a
time-shift insensitive block-circulant singular value decomposition was utilized to
deconvolve Eq. 1.[13] After deconvolution, CBF*R(t) was obtained. The time when the
maximal concentration of the deconvolved tissue curve [CBF*R(t)] occurs is Tmax and the
height of the curve at this maximal concentration was used to measure relative CBF. MTT
was calculated as: [CBV/CBF]. Six parameter rigid registration aligned all images across
time-points for each patient using FSL 3.2 (FMRIB, Oxford, UK).[14]
The “perfusion deficit” for each voxel within the ischemic hemisphere was evaluated using
MTT prolongation (MTTp), TTP, and Tmax. MTTp for each voxel was defined as [MTT
within each voxel of the ischemic hemisphere]–[median MTT of contralateral hemisphere],
whereas TTP and Tmax were absolute measures. Based on previous studies, four
commonly-used thresholds of “perfusion deficits” were chosen to test a range of varying
perfusion deficit severities.[15-17] For MTTp, thresholds of 3, 4, 5, and 6 seconds (s) were
tested. For TTP and Tmax, thresholds of 2, 4, 6, and 8s were tested. The “volume of
reperfusion” (Vreperf) was defined as the volume of voxels with perfusion deficit at tp1, but
no perfusion deficit at tp2. The “percent reperfusion” (%Reperf) was defined as [volume of
reperfusion] / [volume of tp1 perfusion deficit] (Figure 1). The “volume of non-reperfusion”
(Vnon-reperf) was defined as the volume of voxels with perfusion deficit at both tp1 and
tp2. “Tissue salvage” was defined as: [tp1 perfusion deficit volume]–[1 month infarct
volume]. For infarct delineation, hyperintense lesions were manually outlined on the 1
month FLAIR image by a stroke neurologist (A.L.F.). The study team members calculating
the perfusion maps were blinded to all clinical data. Isolated regions of abnormal perfusion
<1 ml were removed from analyses to minimize inclusion of noise-induced variations.
Statistical Analysis
Analyses were performed using SPSS 19.0 and Graphpad Prism 5. P-value<0.05 was
required for significance. A variable-selection method evaluated which reperfusion
measurement (MTTp, TTP, or Tmax) and which threshold best predicted neurological
improvement while adjusting for three baseline clinical variables. Neurological
improvement was defined as admission NIHSS–1 month NIHSS (ΔNIHSS), such that a
positive ΔNIHSS indicates improvement. Specifically, 12 linear regression models (3
parameters, 4 thresholds) were used to fit %Reperf as a predictor of neurological
improvement while adjusting for age, admission NIHSS, and tPA treatment status. The latter
clinical variables were chosen based on an exploratory univariate analysis requiring a p-
value < 0.2 for entry into the model. Age and baseline NIHSS met this criteria, while the
other patient characteristics listed in Table 1 did not. In addition to age and baseline NIHSS,
tPA treatment status was added to each model due to its known effect on clinical outcome
after stroke. [18, 19] The latter three variables were entered into all 12 regression models.
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Regression diagnostics evaluated distributional assumptions of the residuals and functional
form of the covariates.
To measure the effect of reperfusion on tissue fate, Vreperf for each parameter/threshold
was correlated with tissue salvage using Spearman rank correlation (ρ).
Differences in Vreperf, Vnon-reperf, and %Reperf between MTTp vs. Tmax and MTTp vs.
TTP were compared using Wilcoxon matched-pairs signed-rank test. The overlap (similarity
index, SI) between two parameters was assessed using the Dice coefficient, computed as 2*|
A⋂B| / (|A|+|B|), where A and B are regions of tp1 perfusion deficit, reperfusion, or non-
reperfusion from the two MR parameters being compared. SI ranged from 0 and 1
corresponding to no and perfect overlap, respectively.
Results
A total of 63 acute ischemic stroke patients were prospectively scanned. Five patients did
not go on to receive tp2 due to intolerance of tp1 scan due to claustrophobia, poor contrast
delivery on the perfusion weighted imaging, or medical instability, leaving 58 patients who
received the tp2 scan. An additional eight patients who received both tp1 and tp2 scans were
excluded from the analysis due to motion artifact or poor perfusion studies limiting ability to
process the perfusion images. This left 50 patients total for the primary analysis. An
additional ten patients did not complete the one month scan due to death or loss to follow-
up, leaving a total of 40 patients for analyses including the final infarct. Patient
characteristics are shown in Table 1.
MTT-defined reperfusion best predicted neurological improvement at one month
%Reperf was significantly associated with ΔNIHSS for all MTTp thresholds with the
strongest association for the MTTp>3s threshold (P=0.0002). %Reperf was significantly
associated with ΔNIHSS for two Tmax thresholds: 6s (P=0.037) and 8s (P=0.009). %Reperf
was not associated with ΔNIHSS for any TTP threshold (Table 2).
MTT-defined reperfusion best correlated with tissue salvage at 1 month
We then examined which reperfusion parameter/threshold correlated with tissue salvage.
Reperfusion measured by MTTp significantly correlated with tissue salvage across all
MTTp thresholds (strongest was for MTTp>3s and >4s; ρ=0.576, P<0.0001 and ρ =0.555,
P<0.0001, respectively) and for one Tmax threshold, (Tmax>6s: ρ=0.321, P=0.038), but did
not correlate with tissue salvage for any TTP threshold (Table 3).
Reperfused tissue measured by MTTp vs. Tmax and TTP demonstrated low spatial overlap
For a closer look at the differences between the best-performing thresholds from each
parameter, Vreperf, Vnon-reperf, and %Reperf were compared for Tmax and TTP as
compared to MTTp. Vreperf and Vnon-reperf was higher for MTTp than Tmax. Vreperf was
higher for MTTp than TTP (Table 4). We then assessed spatial overlap across the three
parameters for regions of tp1 perfusion deficit, reperfusion, and non-reperfusion across all
subjects. Overlap for the regions of reperfusion between MTTp and Tmax or TTP were low
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at 0.35 and 0.34, respectively (Table 4). To visualize how perfusion changes for a given
parameter/threshold correlated with eventual tissue fate, masks of reperfused and non-
reperfused tissue for MTTp>3s, Tmax>8s, and TTP>6s were overlaid onto the 1 month
FLAIR for two example patients, showing better agreement for MTTp with the final infarct
region (Figure 2).
Discussion
In this prospective observational imaging study of serial MRIs measuring early reperfusion
as a critical determinant of tissue salvage, MTTp-defined reperfusion >3s was the parameter/
threshold most strongly associated with neurological improvement. Weaker associations
were observed for MTTp>4, 5, and 6s and for Tmax>6 and 8s. Tissue salvage was
associated with all MTTp thresholds and Tmax>6s while no significant association was
found with the remaining Tmax thresholds or any TTP threshold. Indeed, we found that the
volumes of reperfusion differed within patients for the optimal MTTp, Tmax, and TTP
thresholds. Moreover, there was little overlap for the regions of reperfusion between MTTp
and Tmax or TTP (Table 4, Figure 2).
Early reperfusion predicts neurological improvement during acute stroke[7-10] and often
serves as an imaging endpoint in clinical trials of acute therapies.[4, 6, 20] Therefore,
knowing which reperfusion measurement most closely reflects neurological improvement
would guide future trial design. In a meta-analysis of clinical trials using diffusion-perfusion
mismatch to select patients for thrombolytic treatment, reperfusion was associated with an
odds ratio of 5.2 for improved clinical outcome as measured by 3 month modified Rankin
scale.[10] Thus far, however, studies have not determined which definition of reperfusion is
most closely tied to neurological improvement after stroke.
Numerous studies have attempted to identify the optimal parameter and threshold measuring
the baseline perfusion deficit as a predictor of final tissue fate and/or clinical outcome, but
have had conflicting results. [15, 16, 21-23] Few studies have considered reperfusion status
when searching for the optimal parameter or threshold.[23, 24] In the Diffusion and
Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) trial, which
measured perfusion using Tmax, penumbral salvage (defined as baseline perfusion deficit
volume-final infarct volume) correlated with infarct growth for Tmax >6s compared to other
thresholds.[24] In patients without reperfusion, Tmax >4s was a more accurate predictor of
final infarct than Tmax >2s.
It is likely that both the quantitative degree of reperfusion as well as the timing of
reperfusion contribute to the ability of reperfusion to accurately predict neurological
improvement. Studies using dual-imaging paradigms to assess reperfusion have typically
defined reperfusion as an “all or none” event. For example, in DEFUSE, stroke subjects
were defined as “reperfused” if the volume of reperfusion was >30% (imaged at 6-9 hours
after stroke onset).[25] In the Echoplanar Imaging Thrombolytic Evaluation Trial
(EPITHET), subjects were defined as “reperfused” if the volume of reperfusion was >90%
(imaged at 3-5 days after onset).[4] More quantitative tissue-based reperfusion with a
continuous range of reperfusion may predict outcomes more precisely. Vessel recanalization
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is another potential marker of early improvement and is associated with good outcome and
reduced mortality;[26] however, recanalization does not always lead to reperfusion at the
tissue level, and the lack of recanalization does not always translate to non-reperfusion,
given the presence collateral flow.[27]
While MTTp-defined reperfusion performed optimally in predicting neurological
improvement (Table 2) and more closely approximated the final infarct than Tmax or TTP
(Table 3, Figure 2), this study was not designed to answer why MTTp performed better.
Clinical and in silico studies provide potential explanations for the short-comings of TTP
and Tmax relative to MTT. While MTT is thought to reflect tissue perfusion at the
microvascular level (defined as CBV/CBF), TTP and Tmax, are largely affected by contrast
“delay” from indirect macrovascular pathways of contrast delivery (i.e. collateral flow).
Calculation of TTP and Tmax includes the time between arrival of contrast at the
contralateral MCA and contrast delivery to the tissue, a delay which may be particularly
significant in the setting of arterial stenosis or occlusion proximal to the tissue of interest.
[28] Simulations suggest that TTP and Tmax are influenced by contrast arrival delay and
may also be affected by dispersion, but to a much lesser degree.[29] It is possible that tissue
may demonstrate abnormal TTP or Tmax due to delay despite adequate and normal
perfusion. Therefore, MTTp may be a more accurate marker of perfusion changes relative to
other time-based perfusion parameters. A relative decrease in sensitivity to voxel-wise
perfusion changes by Tmax may explain why Tmax-measured reperfusion did not correlate
with neurological improvement and tissue salvage at the same threshold.
The study has several limitations. Data was obtained from a single institution. We required
that patients have an NIHSS ≥ 5 to be included; therefore, this cohort included strokes of
greater severity than average stroke patients. Thus, our results may not apply to patients with
low stroke severity. Reperfusion was specifically measured within 6 hours; therefore, our
associations may not be valid outside this time window. The majority of patients received IV
tPA which may bias the results towards any unique effects of tPA beyond reperfusion;
therefore, tPA was included as a covariate. However, the mechanism by which reperfusion
occurred (either spontaneous or via tPA) should not impact our conclusions regarding the
relationship between reperfusion and neurological improvement or tissue salvage. NIHSS
improvement as an endpoint may introduce some heterogeneity as the NIHSS is not equally
represented throughout the brain, however we chose ΔNIHSS in order to capture
improvement from reperfusion and tissue salvage rather than disability scales which may be
influenced by clinical course, co-morbidities, and recovery mechanisms. While this study
focused on common time-based perfusion parameters and specific thresholds of these
parameters used in recent clinical trials, there are several additional parameters, such as CBF
and CBV which are also useful in predicting neurological improvement and tissue salvage
which were not evaluated in this study. Furthermore, there are other factors besides early
reperfusion which affect neurological improvement and tissue salvage, such as intrinsic
tissue vulnerability, which were not accounted for in the present study.
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MTT may be the best time-based perfusion parameter to define clinically-relevant
reperfusion after stroke and may be considered in future studies when reperfusion is used as
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Figure 1. Calculation of Reperfusion
MTTp, TTP, and Tmax perfusion deficits were calculated for tp1 and tp2. The “volume of
reperfusion” was defined as: the volume of voxels with perfusion deficit at tp1, but no
perfusion deficit at tp2. The “percent reperfusion” (%Reperf) was defined as [volume of
reperfusion] / [volume of tp1 perfusion deficit]. In the upper panel, example perfusion maps
(for MTT) at tp1 and tp2 are shown: warm colors represent maximal hypoperfusion, while
cool colors represent normal perfusion (color bar). In the lower panel, the orange mask
delineates the tp1 perfusion deficit defined by MTT >3s longer than the median MTT of the
contralateral hemisphere (MTTp >3s threshold). The blue mask delineates the tp2 perfusion
deficit at MTTp >3s. At tp2, the perfusion deficit shrinks and the non-overlapped region
(yellow arrow) indicates the region of reperfusion.
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Figure 2. Comparison of MTT, Tmax, and TTP in Two Example Patients
Shown are two patient examples of (A) right MCA stroke in a 55 year old man with limited
neurological improvement by 1 month (ΔNIHSS =4) and (B) right MCA stroke in a 54 year
old man with significant neurological improvement by 1 month (ΔNIHSS=13). Reperfused
(green) and non-reperfused (red) tissue for MTTp >3s and Tmax >6s were overlaid on the
final infarct at 1 month. Perfusion changes for MTTp >3s more closely approximated the
final infarct and surrounding non-infarct regions on 1 month FLAIR relative to Tmax >8s or
TTP >6s which overestimate the tissue at risk.
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Time to tp1, hour
* 2.7 [2.1,3.5]
Time to tp2, hour
* 6.2 [6.1,6.5]
Medical History
    Hypertension
† 38 (74%)
    Diabetes
† 17 (33%)
    Congestive Heart Failure
† 6 (12%)
    Tobacco Use
† 12 (24%)
    Coronary Artery Disease
† 14 (28%)
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Table 2







MTTp >3s 0.114 (0.039) 0.0002
MTTp >4s 0.108 (0.028) 0.0004
MTTp >5s 0.103 (0.027) 0.001
MTTp >6s 0.097 (0.027) 0.001
TTP >2s 0.054 (0.047) 0.14
TTP >4s 0.036 (0.051) 0.18
TTP >6s 0.015 (0.050) 0.052
TTP >8s 0.011 (0.047) 0.056
Tmax >2s 0.079 (0.048) 0.12
Tmax >4s 0.063 (0.036) 0.070
Tmax >6s 0.079 (0.036) 0.037
Tmax >8s 0.074 (0.034) 0.009
ΔNIHSS=Admission NIHSS-1month NIHSS;
†
The predictor of interest (%Reperf) was adjusted for age, admission NIHSS, and tPA treatment.
§
β(SE)=Regression coefficient (standard error)
*
P<0.05 for statistical significance.
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Table 3
Correlation of Volume of Reperfusion
†







MTTp >3s 0.576 <0.0001
MTTp >4s 0.555 <0.0001
MTTp >5s 0.457 0.002
MTTp >6s 0.414 0.006
TTP >2s 0.150 0.18
TTP >4s 0.292 0.34
TTP >6s 0.288 0.060
TTP >8s 0.055 0.72
Tmax >2s 0.149 0.35
Tmax >4s 0.266 0.089
Tmax >6s 0.321 0.038
Tmax >8s 0.209 0.18
†
Vreperf=[volume of voxels which had a perfusion deficit at tp1 and no perfusion deficit at tp2].
∞




P<0.05 for statistical significance.
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Table 4
Volume of Reperfusion, Volume of Non-Reperfusion, Percent Reperfusion, and Similarity Index comparing
MTTp to Tmax and TTP
MTTp>3s Tmax>8s TTP>6s
Vreperf, m1






† 41.2 [22.2, 79.2]
27.0 [8.1, 64.6]
*** 33.2 [15.8, 65.3]
%Reperf
† 32.5 [11.6, 48.4] 33.8 [11.9, 56.8] 29.8 [14.9, 43.0]
SI
§
 for tp1 perfusion deficit
0.57 [0.46 ,0.73] 0.58, [0.42, 0.72]
SI
§
 for region of reperfusion
0.35 [0.21, 0.42] 0.34 [0.22, 0.47]
SI
§
 for region of non-reperfusion








P<0.0001; Wilcoxon matched-pairs signed-rank test vs. MTTp>3s.
§
Similarity Index (SI) was computed as 2*|A∩B| / (|A|+|B|) (Dice coefficient), where A and B are regions of overlap for MTTp>3s vs. Tmax>8s
and MTTp>3s vs. TTP>6s; SI ranges from 0 to 1, corresponding to no and perfect agreement, respectively.
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